Financial Performance - Revenue for Q3 2024 reached ¥848,950,396.36, an increase of 22.94% year-over-year[3] - Net profit attributable to shareholders was ¥18,421,446.16, up 143.55% compared to the same period last year[3] - Net profit after deducting non-recurring gains and losses was ¥13,661,385.07, reflecting a 128.68% increase year-over-year[3] - Basic earnings per share for the period was ¥0.02, a rise of 146.76% compared to the previous year[3] - Total revenue for the third quarter reached ¥2,599,501,682.23, an increase of 20.3% compared to ¥2,158,144,636.62 in the same period last year[19] - The company's net profit attributable to shareholders increased to ¥631,256,520.60, compared to ¥599,088,695.49 in the previous year, marking a growth of 5.4%[18] - The net profit for Q3 2024 was CNY 32,539,075.11, a significant increase from CNY 2,642,986.93 in Q3 2023, representing a growth of approximately 1,233%[20] - The total comprehensive income for the period was CNY 113,661,112.03, compared to a loss of CNY 49,079,116.86 in Q3 2023[20] Assets and Liabilities - Total assets at the end of the period amounted to ¥5,953,927,522.23, representing a 1.14% increase from the end of the previous year[3] - The total assets of the company amounted to ¥5,953,927,522.23, compared to ¥5,886,856,823.03 at the beginning of the period, reflecting a growth of 1.1%[18] - The total liabilities decreased to ¥2,785,259,907.53 from ¥2,832,786,329.61, a reduction of 1.7%[18] - Cash and cash equivalents decreased to ¥295,473,509.54 from ¥365,427,878.59, a decline of 19.1%[16] - Accounts receivable rose to ¥482,275,192.83, up from ¥433,429,476.43, indicating an increase of 11.3%[16] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥9,803,728.77, an increase of 113.27% year-over-year[6] - The cash flow from operating activities showed a net inflow of CNY 9,803,728.77, a recovery from a net outflow of CNY 73,879,866.00 in Q3 2023[22] - The company incurred a net cash outflow from investing activities of CNY 81,054,546.80, an improvement from a net outflow of CNY 157,536,916.11 in the same quarter last year[23] - The financing activities generated a net cash outflow of CNY 11,280,171.95, compared to a net inflow of CNY 107,713,537.17 in Q3 2023[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 47,143, with the top ten shareholders holding significant stakes[7] - The top two shareholders, Qian Zhida and Qian Zhiming, are the controlling shareholders and actual controllers of the company[9] - The top ten shareholders include several private equity funds managed by Shenzhen Bisheng Private Equity Fund Management Co., Ltd.[9] - The top ten unrestricted shareholders hold a total of 64,348,860 shares, representing a significant portion of the company's equity[11] Fundraising and Projects - The company plans to raise a total of up to 800 million RMB for the construction project of 1,150 tons of iodine contrast agent raw materials and to supplement working capital[11] - The fundraising amount has been adjusted from 800 million RMB to 442 million RMB for the construction of 600 tons of iodinated contrast agent raw materials[12] - The company is still in the process of promoting the issuance of shares to specific targets, which requires approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[14] - The company held multiple board meetings to discuss and approve the issuance of A-shares to specific targets throughout 2023[11] - The company has not completed the issuance of A-shares to specific targets as of October 2024, and the timeline for approval remains uncertain[14] - The company has extended the validity period for the board's authorization to handle the issuance of shares to specific targets by 12 months[13] Research and Development - Research and development expenses for the quarter were ¥94,138,259.64, compared to ¥80,522,839.21, representing an increase of 16.9%[19] - The company’s long-term investments increased slightly to ¥7,502,652.90 from ¥7,500,022.71, showing a marginal growth[16] Tax and Other Income - The company recorded a tax expense of CNY 4,502,370.36, a decrease from CNY 16,015,583.77 in the previous year[20] - Other comprehensive income after tax was CNY 81,122,036.92, a recovery from a loss of CNY 51,722,103.79 in Q3 2023[20]
兄弟科技(002562) - 2024 Q3 - 季度财报